Literature DB >> 16143648

Vascular dysfunction produced by hyperhomocysteinemia is more severe in the presence of low folate.

J David Symons1, John C Rutledge, U Simonsen, Roshny A Pattathu.   

Abstract

Earlier we reported that dietary folate depletion causes hyperhomocysteinemia (HHcy) and arterial dysfunction in rats (Symons JD, Mullick AE, Ensunsa JL, Ma AA, and Rutledge JC. Arterioscler Thromb Vasc Biol 22: 772-780, 2002). Both HHcy and low folate (LF) are risk factors for cardiovascular disease. Therefore, the dysfunction we observed could have resulted from HHcy, LF, and/or their combination (HHcy + LF). We tested the hypothesis that HHcy-induced vascular dysfunction is more severe in the presence of LF. Four groups of rats consumed diets for approximately 10 wk that produced plasma homocysteine (microM) and liver folate (microg folate/g liver) concentrations, respectively, of 7 +/- 1 and 15 +/- 1 (Control; Con; n = 16), 17 +/- 2 and 15 +/- 2 (HHcy; n = 17), 10 +/- 1 and 8 +/- 1 (LF; n = 14), and 21 +/- 2 and 8 +/- 1 (HHcy + LF; n = 18). We observed that maximal ACh-evoked vasorelaxation was greatest in aortas and mesenteric arteries from Con rats vs. all groups. While the extent of dysfunction was similar between LF and HHcy animals, it was less severe compared with arteries from HHcy + LF rats. Maximal ACh-evoked vasorelaxation in coronary arteries was not different between Con and LF rats, but both were greater than HHcy + LF animals. In segments of aortas, 1) ACh-evoked vasorelaxation was similar among groups after incubation with the nonenzymatic intracellular O2(-) scavenger Tiron, 2) vascular O2(-) estimated using dihydroethidium staining was greatest in HHcy + LF vs. all groups, and 3) tension development in response to nitric oxide (NO) synthase inhibition was greatest in Con vs. all other groups. We conclude that HHcy + LF evokes greater dysfunction than either HHcy alone (aortas, mesentery) or LF alone (aortas, mesentery, coronary), likely by producing more O2(-) within the vasculature and thereby reducing NO bioavailability.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16143648     DOI: 10.1152/ajpheart.00765.2005

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  15 in total

1.  Mesenteric vascular remodeling in hyperhomocysteinemia.

Authors:  C Munjal; S Givvimani; N Qipshidze; N Tyagi; J C Falcone; S C Tyagi
Journal:  Mol Cell Biochem       Date:  2010-11-13       Impact factor: 3.396

2.  Knockout of insulin receptors in cardiomyocytes attenuates coronary arterial dysfunction induced by pressure overload.

Authors:  J David Symons; Ping Hu; Ying Yang; Xiaohui Wang; Quan-Jiang Zhang; Adam R Wende; Crystal L Sloan; Sandra Sena; E Dale Abel; Sheldon E Litwin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-10-22       Impact factor: 4.733

3.  Different mechanisms involved in liraglutide and glucagon-like peptide-1 vasodilatation in rat mesenteric small arteries.

Authors:  Maj Bangshaab; Alejandro Gutierrez; Khiem Dinh Huynh; Jakob Schöllhammer Knudsen; Daniel Dias Rufino Arcanjo; Asbjørn G Petersen; Jørgen Rungby; Michael Gejl; Ulf Simonsen
Journal:  Br J Pharmacol       Date:  2018-12-09       Impact factor: 8.739

Review 4.  Micronutrients and their supplementation in chronic cardiac failure. An update beyond theoretical perspectives.

Authors:  Klaus K Witte; Andrew L Clark
Journal:  Heart Fail Rev       Date:  2006-03       Impact factor: 4.214

Review 5.  Hydroethidine- and MitoSOX-derived red fluorescence is not a reliable indicator of intracellular superoxide formation: another inconvenient truth.

Authors:  Jacek Zielonka; B Kalyanaraman
Journal:  Free Radic Biol Med       Date:  2010-01-29       Impact factor: 7.376

6.  Distinct functions of vascular endothelial and smooth muscle PPARgamma in regulation of blood pressure and vascular tone.

Authors:  Ningning Wang; J David Symons; Hui Zhang; Zhanjun Jia; Frank J Gonzalez; Tianxin Yang
Journal:  Toxicol Pathol       Date:  2008-12-15       Impact factor: 1.902

7.  Heat and α1-adrenergic responsiveness in human skeletal muscle feed arteries: the role of nitric oxide.

Authors:  Stephen J Ives; Robert H I Andtbacka; Sun Hyung Kwon; Yan-Ting Shiu; Ting Ruan; R Dirk Noyes; Quan-Jiang Zhang; J David Symons; Russell S Richardson
Journal:  J Appl Physiol (1985)       Date:  2012-10-04

8.  Chronic diet-induced hyperhomocysteinemia impairs eNOS regulation in mouse mesenteric arteries.

Authors:  Robin C Looft-Wilson; Blair S Ashley; Janelle E Billig; Madeline R Wolfert; Lindsay A Ambrecht; Shawn E Bearden
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-04-30       Impact factor: 3.619

9.  Contribution of insulin and Akt1 signaling to endothelial nitric oxide synthase in the regulation of endothelial function and blood pressure.

Authors:  J David Symons; Shawna L McMillin; Christian Riehle; Jason Tanner; Milda Palionyte; Elaine Hillas; Deborah Jones; Robert C Cooksey; Morris J Birnbaum; Donald A McClain; Quan-Jiang Zhang; Derrick Gale; Lloyd J Wilson; E Dale Abel
Journal:  Circ Res       Date:  2009-04-02       Impact factor: 17.367

Review 10.  Murine models of hyperhomocysteinemia and their vascular phenotypes.

Authors:  Sanjana Dayal; Steven R Lentz
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-06-12       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.